Skip to main content Skip to main menu
UF Health University of Florida
Shannon E. Boye Laboratory Department of Pediatrics in the College of Medicine
Support our Mission
Our Research Overview

Publications

Peer Reviewed Manuscripts

  1. Kellish PC, Marsic D, Crosson SM, Choudhury S, Scalabrino ML, Strang CE, Hill J, McCullough KT, Peterson JJ, Fajardo D, Gupte S, Makal V, Kondratov O, Kondratova L, Iyer S, Witherspoon CD, Gamlin PD, Zolotukhin S, Boye SL, Boye SE. Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion. Mol Ther. 2023 Dec 6;31(12):3441-3456. doi: 10.1016/j.ymthe.2023.10.001. Epub 2023 Oct 9. PubMed PMID: 37814449; PubMed Central PMCID: PMC10727955.
  2. Lau SC, Grati M, Isgrig K, Sinan M, Calabro KR, Zhu J, Ishibashi Y, Ozgur Z, Wafa T, Belyantseva IA, Fitzgerald T, Friedman TB, Boye SL, Boye SE, Chien WW. Dual-AAV vector-mediated expression of MYO7A improves vestibular function in a mouse model of Usher syndrome 1B. Mol Ther Methods Clin Dev. 2023 Sep 14;30:534-545. doi: 10.1016/j.omtm.2023.08.012. eCollection 2023 Sep 14. PubMed PMID: 37693946; PubMed Central PMCID: PMC10491803.select
  3. Mellen RW, Calabro KR, McCullough KT, Crosson SM, Cova A, Fajardo D, Xu E, Boye SL, Boye SE. Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6. Mol Ther Methods Clin Dev. 2023 Sep 14;30:48-64. doi: 10.1016/j.omtm.2023.05.020. eCollection 2023 Sep 14. PubMed PMID: 37361352; PubMed Central PMCID: PMC10285452.select
  4. Periasamy R, Patel DD, Boye SL, Boye SE, Lipinski DM. Improving retinal vascular endothelial cell tropism through rational rAAV capsid design. PLoS One. 2023;18(5):e0285370. doi: 10.1371/journal.pone.0285370. eCollection 2023. PubMed PMID: 37167304; PubMed Central PMCID: PMC10174500.select
  5. Boye SL, O’Riordan C, Morris J, Lukason M, Compton D, Baek R, Elmore DM, Peterson JJ, Fajardo D, McCullough KT, Scaria A, McVie-Wylie A, Boye SE. Preclinical studies in support of phase I/II clinical trials to treat GUCY2D-associated Leber congenital amaurosis. Mol Ther Methods Clin Dev. 2023 Mar 9;28:129-145. doi: 10.1016/j.omtm.2022.12.007. eCollection 2023 Mar 9. PubMed PMID: 36654798; PubMed Central PMCID: PMC9830033.
  6. Boye SE, Durham T, Laster A, Gelfman CM, Sahel JA. Identifying and Overcoming Challenges in Developing Effective Treatments for Usher 1B: A Workshop Report. Transl Vis Sci Technol. 2023 Feb 1;12(2):2. doi: 10.1167/tvst.12.2.2. PubMed PMID: 36723965; PubMed Central PMCID: PMC9904327.select
  7. Calabro KR, Boye SL, Boye SE. Optimization of Capillary-Based Western Blotting for MYO7A. Adv Exp Med Biol. 2023;1415:125-130. doi: 10.1007/978-3-031-27681-1_19. PubMed PMID: 37440024.select
  8. Cao Y, Fajardo D, Guerrero-Given D, Samuel MA, Ohtsuka T, Boye SE, Kamasawa N, Martemyanov KA. Post-developmental plasticity of the primary rod pathway allows restoration of visually guided behaviors. Curr Biol. 2022 Nov 21;32(22):4783-4796.e3. doi: 10.1016/j.cub.2022.09.016. Epub 2022 Sep 29. PubMed PMID: 36179691; PubMed Central PMCID: PMC9691582.select
  9. Jacobson SG, Cideciyan AV, Ho AC, Roman AJ, Wu V, Garafalo AV, Sumaroka A, Krishnan AK, Swider M, Mascio AA, Kay CN, Yoon D, Fujita KP, Boye SL, Peshenko IV, Dizhoor AM, Boye SE. Night vision restored in days after decades of congenital blindness. iScience. 2022 Oct 21;25(10):105274. doi: 10.1016/j.isci.2022.105274. eCollection 2022 Oct 21. PubMed PMID: 36274938; PubMed Central PMCID: PMC9579015.select
  10. Ma X, Sechrest ER, Fajardo D, Zhu P, Dyka F, Wang Y, Lobanova E, Boye SE, Baehr W, Deng WT. Gene Therapy in Opn1mw(-/-)/Opn1sw(-/-) Mice and Implications for Blue Cone Monochromacy Patients with Deletion Mutations. Hum Gene Ther. 2022 Jul;33(13-14):708-718. doi: 10.1089/hum.2021.298. Epub 2022 May 16. PubMed PMID: 35272502; PubMed Central PMCID: PMC9347391.select
  11. Gilkes JA, Judkins BL, Herrera BN, Mandel RJ, Boye SL, Boye SE, Srivastava A, Heldermon CD. Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouse. Gene Ther. 2021 Aug;28(7-8):447-455. doi: 10.1038/s41434-020-00206-w. Epub 2020 Nov 26. PubMed PMID: 33244179; PubMed Central PMCID: PMC8149485.select
  12. Jacobson SG, Cideciyan AV, Ho AC, Peshenko IV, Garafalo AV, Roman AJ, Sumaroka A, Wu V, Krishnan AK, Sheplock R, Boye SL, Dizhoor AM, Boye SE. Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations. iScience. 2021 May 21;24(5):102409. doi: 10.1016/j.isci.2021.102409. eCollection 2021 May 21. PubMed PMID: 33997691; PubMed Central PMCID: PMC8099775.select
  13. Crosson SM, Bennett A, Fajardo D, Peterson JJ, Zhang H, Li W, Leahy MT, Jennings CK, Boyd RF, Boye SL, Agbandge-McKenna M, Boye SE. Effects of Altering HSPG Binding and Capsid Hydrophilicity on Retinal Transduction by AAV. J Virol. 2021 Apr 26;95(10). doi: 10.1128/JVI.02440-20. Epub 2021 Mar 3. PubMed PMID: 33658343; PubMed Central PMCID: PMC8139652.select
  14. Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, Boye SL, Boye SE, George LA, Salabarria S, Corti M, Byrne BJ, Tremblay JP. Current Clinical Applications of In Vivo Gene Therapy with AAVs. Mol Ther. 2021 Feb 3;29(2):464-488. doi: 10.1016/j.ymthe.2020.12.007. Epub 2020 Dec 10. Review. PubMed PMID: 33309881; PubMed Central PMCID: PMC7854298.select
  15. Sasaki Y, Kakita H, Kubota S, Sene A, Lee TJ, Ban N, Dong Z, Lin JB, Boye SL, DiAntonio A, Boye SE, Apte RS, Milbrandt J. SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration. Elife. 2020 Oct 27;9. doi: 10.7554/eLife.62027. PubMed PMID: 33107823; PubMed Central PMCID: PMC7591247.select
  16. Mainland JD, Barlow LA, Munger SD, Millar SE, Vergara MN, Jiang P, Schwob JE, Goldstein BJ, Boye SE, Martens JR, Leopold DA, Bartoshuk LM, Doty RL, Hummel T, Pinto JM, Trimmer C, Kelly C, Pribitkin EA, Reed DR. Identifying Treatments for Taste and Smell Disorders: Gaps and Opportunities. Chem Senses. 2020 Oct 9;45(7):493-502. doi: 10.1093/chemse/bjaa038. PubMed PMID: 32556127; PubMed Central PMCID: PMC7545248.select
  17. Boye SL, Choudhury S, Crosson S, Di Pasquale G, Afione S, Mellen R, Makal V, Calabro KR, Fajardo D, Peterson J, Zhang H, Leahy MT, Jennings CK, Chiorini JA, Boyd RF, Boye SE. Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy. Mol Ther. 2020 Jun 3;28(6):1464-1478. doi: 10.1016/j.ymthe.2020.04.002. Epub 2020 Apr 11. PubMed PMID: 32304666; PubMed Central PMCID: PMC7264435.select
  18. Kwon HJ, Qing K, Ponnazhagan S, Wang XS, Markusic DM, Gupte S, Boye SE, Srivastava A. Adeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune Response. Hum Gene Ther. 2020 May;31(9-10):565-574. doi: 10.1089/hum.2020.018. Epub 2020 Apr 23. PubMed PMID: 32220217; PubMed Central PMCID: PMC7232703.select
  19. Goodwin MS, Croft CL, Futch HS, Ryu D, Ceballos-Diaz C, Liu X, Paterno G, Mejia C, Deng D, Menezes K, Londono L, Arjona K, Parianos M, Truong V, Rostonics E, Hernandez A, Boye SL, Boye SE, Levites Y, Cruz PE, Golde TE. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS. Mol Neurodegener. 2020 Mar 2;15(1):15. doi: 10.1186/s13024-020-00361-z. PubMed PMID: 32122372; PubMed Central PMCID: PMC7053119.select
  20. Calabro KR, Boye SL, Choudhury S, Fajardo D, Peterson JJ, Li W, Crosson SM, Kim MJ, Ding D, Salvi R, Someya S, Boye SE. A Novel Mouse Model of MYO7A USH1B Reveals Auditory and Visual System Haploinsufficiencies. Front Neurosci. 2019;13:1255. doi: 10.3389/fnins.2019.01255. eCollection 2019. PubMed PMID: 31824252; PubMed Central PMCID: PMC6883748.select
  21. McCullough KT, Boye SL, Fajardo D, Calabro K, Peterson JJ, Strang CE, Chakraborty D, Gloskowski S, Haskett S, Samuelsson S, Jiang H, Witherspoon CD, Gamlin PD, Maeder ML, Boye SE. Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque. Hum Gene Ther. 2019 May;30(5):571-589. doi: 10.1089/hum.2018.193. Epub 2018 Dec 20. PubMed PMID: 30358434; PubMed Central PMCID: PMC6534089.select
  22. Gamlin PD, Alexander JJ, Boye SL, Witherspoon CD, Boye SE. SubILM Injection of AAV for Gene Delivery to the Retina. Methods Mol Biol. 2019;1950:249-262. doi: 10.1007/978-1-4939-9139-6_14. PubMed PMID: 30783978; PubMed Central PMCID: PMC6700748.select
  23. Santiago CP, Keuthan CJ, Boye SL, Boye SE, Imam AA, Ash JD. A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration. Mol Ther. 2018 Oct 3;26(10):2407-2417. doi: 10.1016/j.ymthe.2018.07.016. Epub 2018 Jul 19. PubMed PMID: 30078764; PubMed Central PMCID: PMC6171322.select
  24. Kanaan NM, Sellnow RC, Boye SL, Coberly B, Bennett A, Agbandje-McKenna M, Sortwell CE, Hauswirth WW, Boye SE, Manfredsson FP. Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS. Mol Ther Nucleic Acids. 2017 Sep 15;8:184-197. doi: 10.1016/j.omtn.2017.06.011. Epub 2017 Jun 21. PubMed PMID: 28918020; PubMed Central PMCID: PMC5503098.select
  25. Beltran WA, Cideciyan AV, Boye SE, Ye GJ, Iwabe S, Dufour VL, Marinho LF, Swider M, Kosyk MS, Sha J, Boye SL, Peterson JJ, Witherspoon CD, Alexander JJ, Ying GS, Shearman MS, Chulay JD, Hauswirth WW, Gamlin PD, Jacobson SG, Aguirre GD. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations. Mol Ther. 2017 Aug 2;25(8):1866-1880. doi: 10.1016/j.ymthe.2017.05.004. Epub 2017 May 27. PubMed PMID: 28566226; PubMed Central PMCID: PMC5542804.select
  26. Jacobson SG, Cideciyan AV, Sumaroka A, Roman AJ, Charng J, Lu M, Choudhury S, Schwartz SB, Heon E, Fishman GA, Boye SE. Defining Outcomes for Clinical Trials of Leber Congenital Amaurosis Caused by GUCY2D Mutations. Am J Ophthalmol. 2017 May;177:44-57. doi: 10.1016/j.ajo.2017.02.003. Epub 2017 Feb 16. PubMed PMID: 28212877.select
  27. Cho JH, Swanson CJ, Chen J, Li A, Lippert LG, Boye SE, Rose K, Sivaramakrishnan S, Chuong CM, Chow RH. The GCaMP-R Family of Genetically Encoded Ratiometric Calcium Indicators. ACS Chem Biol. 2017 Apr 21;12(4):1066-1074. doi: 10.1021/acschembio.6b00883. Epub 2017 Mar 1. PubMed PMID: 28195691; PubMed Central PMCID: PMC5572679.select
  28. Boye SE. Increased vulnerability of photoreceptors to aberrant splicing highlight the utility of AON-based therapy for CEP290-LCA. Stem Cell Investig. 2016;3:96. doi: 10.21037/sci.2016.12.01. eCollection 2016. PubMed PMID: 28078276; PubMed Central PMCID: PMC5222712.select
  29. Choudhury S, Strang CE, Alexander JJ, Scalabrino ML, Lynch Hill J, Kasuga DT, Witherspoon CD, Boye SL, Gamlin PD, Boye SE. Novel Methodology for Creating Macaque Retinas with Sortable Photoreceptors and Ganglion Cells. Front Neurosci. 2016;10:551. doi: 10.3389/fnins.2016.00551. eCollection 2016. PubMed PMID: 27990105; PubMed Central PMCID: PMC5131003.select
  30. Xie K, Colgan LA, Dao MT, Muntean BS, Sutton LP, Orlandi C, Boye SL, Boye SE, Shih CC, Li Y, Xu B, Smith RG, Yasuda R, Martemyanov KA. NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum. Curr Biol. 2016 Nov 21;26(22):2992-3003. doi: 10.1016/j.cub.2016.09.010. Epub 2016 Oct 20. PubMed PMID: 27773571; PubMed Central PMCID: PMC5121064.select
  31. Boye SL, Olshevskaya EV, Peshenko IV, McCullough KT, Boye SE, Dizhoor AM. Functional study of two biochemically unusual mutations in GUCY2D Leber congenital amaurosis expressed via adenoassociated virus vector in mouse retinas. Mol Vis. 2016;22:1342-1351. eCollection 2016. PubMed PMID: 27881908; PubMed Central PMCID: PMC5108460.select
  32. Boye SE, Alexander JJ, Witherspoon CD, Boye SL, Peterson JJ, Clark ME, Sandefer KJ, Girkin CA, Hauswirth WW, Gamlin PD. Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina. Hum Gene Ther. 2016 Aug;27(8):580-97. doi: 10.1089/hum.2016.085. PubMed PMID: 27439313; PubMed Central PMCID: PMC4991591.select
  33. Boyd RF, Boye SL, Conlon TJ, Erger KE, Sledge DG, Langohr IM, Hauswirth WW, Komáromy AM, Boye SE, Petersen-Jones SM, Bartoe JT. Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs. Gene Ther. 2016 Jun;23(6):548-56. doi: 10.1038/gt.2016.31. Epub 2016 Apr 7. PubMed PMID: 27052802; PubMed Central PMCID: PMC4891289.select
  34. Boye SL, Bennett A, Scalabrino ML, McCullough KT, Van Vliet K, Choudhury S, Ruan Q, Peterson J, Agbandje-McKenna M, Boye SE. Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors. J Virol. 2016 Apr;90(8):4215-4231. doi: 10.1128/JVI.00200-16. Print 2016 Apr. PubMed PMID: 26865709; PubMed Central PMCID: PMC4810560.select
  35. Ildefonso CJ, Jaime H, Brown EE, Iwata RL, Ahmed CM, Massengill MT, Biswal MR, Boye SE, Hauswirth WW, Ash JD, Li Q, Lewin AS. Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide. Invest Ophthalmol Vis Sci. 2016 Feb;57(2):372-86. doi: 10.1167/iovs.15-17703. PubMed PMID: 26842755; PubMed Central PMCID: PMC5110262.select
  36. Boyd RF, Sledge DG, Boye SL, Boye SE, Hauswirth WW, Komáromy AM, Petersen-Jones SM, Bartoe JT. Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs. Gene Ther. 2016 Feb;23(2):223-30. doi: 10.1038/gt.2015.96. Epub 2015 Oct 15. PubMed PMID: 26467396; PubMed Central PMCID: PMC4840844.select
  37. Boye SE. A Mini-review: Animal Models of GUCY2D Leber Congenital Amaurosis (LCA1). Adv Exp Med Biol. 2016;854:253-8. doi: 10.1007/978-3-319-17121-0_34. Review. PubMed PMID: 26427419.select
  38. Ye GJ, Budzynski E, Sonnentag P, Nork TM, Sheibani N, Gurel Z, Boye SL, Peterson JJ, Boye SE, Hauswirth WW, Chulay JD. Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases. Hum Gene Ther. 2016 Jan;27(1):72-82. doi: 10.1089/hum.2015.130. PubMed PMID: 26603570; PubMed Central PMCID: PMC4741229.select
  39. Scalabrino ML, Boye SL, Fransen KM, Noel JM, Dyka FM, Min SH, Ruan Q, De Leeuw CN, Simpson EM, Gregg RG, McCall MA, Peachey NS, Boye SE. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. Hum Mol Genet. 2015 Nov 1;24(21):6229-39. doi: 10.1093/hmg/ddv341. Epub 2015 Aug 26. PubMed PMID: 26310623; PubMed Central PMCID: PMC4612567.select
  40. Lipinski DM, Reid CA, Boye SL, Peterson JJ, Qi X, Boye SE, Boulton ME, Hauswirth WW. Systemic Vascular Transduction by Capsid Mutant Adeno-Associated Virus After Intravenous Injection. Hum Gene Ther. 2015 Nov;26(11):767-76. doi: 10.1089/hum.2015.097. Epub 2015 Sep 29. PubMed PMID: 26359319; PubMed Central PMCID: PMC4651034.select
  41. Boye SL, Peterson JJ, Choudhury S, Min SH, Ruan Q, McCullough KT, Zhang Z, Olshevskaya EV, Peshenko IV, Hauswirth WW, Ding XQ, Dizhoor AM, Boye SE. Gene Therapy Fully Restores Vision to the All-Cone Nrl(-/-) Gucy2e(-/-) Mouse Model of Leber Congenital Amaurosis-1. Hum Gene Ther. 2015 Sep;26(9):575-92. doi: 10.1089/hum.2015.053. Epub 2015 Aug 6. PubMed PMID: 26247368; PubMed Central PMCID: PMC4575531.select
  42. Bogner B, Boye SL, Min SH, Peterson JJ, Ruan Q, Zhang Z, Reitsamer HA, Hauswirth WW, Boye SE. Capsid Mutated Adeno-Associated Virus Delivered to the Anterior Chamber Results in Efficient Transduction of Trabecular Meshwork in Mouse and Rat. PLoS One. 2015;10(6):e0128759. doi: 10.1371/journal.pone.0128759. eCollection 2015. PubMed PMID: 26052939; PubMed Central PMCID: PMC4460001.select
  43. Ildefonso CJ, Jaime H, Biswal MR, Boye SE, Li Q, Hauswirth WW, Lewin AS. Gene therapy with the caspase activation and recruitment domain reduces the ocular inflammatory response. Mol Ther. 2015 May;23(5):875-884. doi: 10.1038/mt.2015.30. Epub 2015 Feb 20. PubMed PMID: 25698151; PubMed Central PMCID: PMC4427880.select
  44. Benskey MJ, Kuhn NC, Galligan JJ, Garcia J, Boye SE, Hauswirth WW, Mueller C, Boye SL, Manfredsson FP. Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants. Mol Ther. 2015 Mar;23(3):488-500. doi: 10.1038/mt.2015.7. Epub 2015 Jan 16. PubMed PMID: 25592336; PubMed Central PMCID: PMC4351472.select
  45. Ildefonso CJ, Jaime H, Rahman MM, Li Q, Boye SE, Hauswirth WW, Lucas AR, McFadden G, Lewin AS. Gene delivery of a viral anti-inflammatory protein to combat ocular inflammation. Hum Gene Ther. 2015 Jan;26(1):59-68. doi: 10.1089/hum.2014.089. PubMed PMID: 25420215; PubMed Central PMCID: PMC4303190.select
  46. Boye SE. Leber congenital amaurosis caused by mutations in GUCY2D. Cold Spring Harb Perspect Med. 2014 Sep 25;5(1):a017350. doi: 10.1101/cshperspect.a017350. Review. PubMed PMID: 25256176; PubMed Central PMCID: PMC4292079.select
  47. O’Reilly M, Federoff HJ, Fong Y, Kohn DB, Patterson AP, Ahmed N, Asokan A, Boye SE, Crystal RG, De Oliveira S, Gargiulo L, Harper SQ, Ikeda Y, Jambou R, Montgomery M, Prograis L, Rosenthal E, Sterman DH, Vandenberghe LH, Zoloth L, Abedi M, Adair J, Adusumilli PS, Goins WF, Gray J, Monahan P, Popplewell L, Sena-Esteves M, Tannous B, Weber T, Wierda W, Gopal-Srivastava R, McDonald CL, Rosenblum D, Corrigan-Curay J. Gene therapy: charting a future course–summary of a National Institutes of Health Workshop, April 12, 2013. Hum Gene Ther. 2014 Jun;25(6):488-97. doi: 10.1089/hum.2014.045. Review. PubMed PMID: 24773122; PubMed Central PMCID: PMC4064731.select
  48. Boye SE. Insights gained from gene therapy in animal models of retGC1 deficiency. Front Mol Neurosci. 2014;7:43. doi: 10.3389/fnmol.2014.00043. eCollection 2014. Review. PubMed PMID: 24860425; PubMed Central PMCID: PMC4030156.select
  49. Dyka FM, Boye SL, Chiodo VA, Hauswirth WW, Boye SE. Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A. Hum Gene Ther Methods. 2014 Apr;25(2):166-77. doi: 10.1089/hgtb.2013.212. PubMed PMID: 24568220; PubMed Central PMCID: PMC3991978.select
  50. Boye SE, Huang WC, Roman AJ, Sumaroka A, Boye SL, Ryals RC, Olivares MB, Ruan Q, Tucker BA, Stone EM, Swaroop A, Cideciyan AV, Hauswirth WW, Jacobson SG. Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: determining the timing and expectation of therapy. PLoS One. 2014;9(3):e92928. doi: 10.1371/journal.pone.0092928. eCollection 2014. PubMed PMID: 24671090; PubMed Central PMCID: PMC3966841.
View more Publications
Visit Dr. Boye of Google Scholar

Book Chapters

  1. Title: Retinal Disorders: Genetic Approaches to Diagnosis and Treatment Editors: Eric Pierce, Richard Masland, Joan Miller Publisher: Cold Spring Harbor Press Chapter Title: Leber congenital amaurosis due to mutations in GUCY2D Author: Shannon E. Boye 2013
  2.  Title: A Guide to Human Gene Therapy Editors: Herzog and Zolotukhin Publisher: World Scientific Chapter Title: Retinal Diseases Authors: Shannon E Boye, Sanford L Boye, William W. Hauswirth 2009
  3. Title: Mouse Visual System Editors: Chalupa and Williams Publisher: MIT Press Chapter Title: AAV Gene Therapy in Mouse Models of Retinal Degeneration Authors: SE Boye , SL Boye, WW Hauswirth 2008
  4. Title: Regenerative Medicine Editors: Robert C. Fisher and Edward W. Scott Publisher: Jones and Bartlett Chapter Title: Retina Authors: Hilda Petrs-Silva, Shannon Boye and William W. Hauswirth

Collections Edited

  1. Frontiers in Neuroscience “Ocular Gene Therapy: From Basic Research to Translational Studies” Editors: Shannon E. Boye, Stylianos Michalakis, Simon Petersen-Jones, Hildegard Büning. Collection in process 2015-2017

Other

  1. Sanford L. Boye and Shannon E. Boye. “Genetic Therapies for Inherited Retinal Disease”. Invited submission to ‘Retinal Physician’ magazine (peer reviewed). Published 5-1-15